Impact BioMedical Inc.
Organization details
- Legal name
- Impact BioMedical Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IBO
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001834105
- EIN
- 85-3926944
Board of directors
-
Castel Berisford Hibbert · DirectorSince 2024
-
Christian Thomas Zimmerman · DirectorSince 2024
-
David K. Keene · DirectorSince 2024
-
Elise Brownell · DirectorSince 2024
-
Frank D. Heuszel · Director · Chief Executive OfficerSince 2024
-
Heng Fai Ambrose Chan · DirectorSince 2025
-
Jason Grady · DirectorSince 2024
-
Melissa Kaye Sims · DirectorSince 2024
Chief executives
Director election results
Annual meeting of November 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.8%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
Board connections
2 of this board's directors also sit on 3 other boards. 1 is in the same sector.
- via Frank D. Heuszel and Heng Fai Ambrose Chan
- via Heng Fai Ambrose Chan
-
EnerSyn Global Inc. Same sectorvia Heng Fai Ambrose Chan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $58,162
- 4 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 7, 2026 | Elise Brownell Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Heng Fai Ambrose Chan Director, 10% owner | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Jason Grady Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Castel Berisford Hibbert Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Macko Todd D Officer (Chief Financial Officer) | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | David K. Keene Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Melissa Kaye Sims Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Christian Thomas Zimmerman Director | Grant or award | −4,170 | $4.54 | $18,932 |
| Oct 7, 2026 | Suseck Mark Officer (Chief Operating Officer) | Grant or award | −4,170 | $4.54 | $18,932 |
| Sep 24, 2026 | DSS, INC. 10% owner | Open-market sale | −156 | $7.06 | $1,101 |
| Sep 23, 2026 | DSS, INC. 10% owner | Open-market sale | −27 | $6.95 | $188 |
| Sep 22, 2026 | DSS, INC. 10% owner | Open-market sale | −723 | $0.55 | $398 |
| Mar 27, 2026 | Macko Todd D Officer (Chief Financial Officer) | Open-market sale | −43,400 | $0.56 | $24,304 |
| Mar 25, 2026 | Macko Todd D Officer (Chief Financial Officer) | Open-market sale | −1,600 | $0.60 | $960 |
| Mar 23, 2026 | Jason Grady Director | Open-market sale | −50,000 | $0.65 | $32,500 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Impact BioMedical Inc.
Who is the CEO of Impact BioMedical Inc.?
Frank D. Heuszel has been Impact BioMedical Inc.'s CEO and President since September 2024.
How many directors are on Impact BioMedical Inc.'s board?
Impact BioMedical Inc.'s board has 8 directors: Castel Berisford Hibbert, Christian Thomas Zimmerman, David K. Keene, Elise Brownell, Frank D. Heuszel, Heng Fai Ambrose Chan, Jason Grady and Melissa Kaye Sims.
Are Impact BioMedical Inc. insiders buying or selling shares?
Over the last 12 months, Impact BioMedical Inc. insiders made no open-market purchases and sold $58,162 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="impact-biomedical-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.